Search Page

1

Cite

Share

A systematic review of insomnia and complementary medicine.

Sarris J, Byrne GJ. Sarris J, et al. Sleep Med Rev. 2011 Apr;15(2):99-106. doi: 10.1016/j.smrv.2010.04.001. Epub 2010 Jun 8. Sleep Med Rev. 2011. PMID: 20965131 Review.

Cite

Share

2

Cite

Share

Corrigendum to "A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder". [J Affect Disord. 15 (2020) 233-238].

Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Marx W, Pariante C, Berk M, Jacka F, Su KP. Guu TW, et al. Among authors: sarris j. J Affect Disord. 2020 Sep 1;274:1226-1227. doi: 10.1016/j.jad.2020.06.007. Epub 2020 Jun 22. J Affect Disord. 2020. PMID: 32663964 No abstract available.

Cite

Share

3

Cite

Share

Kava for generalised anxiety disorder: A 16-week double-blind, randomised, placebo-controlled study.

Sarris J, Byrne GJ, Bousman CA, Cribb L, Savage KM, Holmes O, Murphy J, Macdonald P, Short A, Nazareth S, Jennings E, Thomas SR, Ogden E, Chamoli S, Scholey A, Stough C. Sarris J, et al. Aust N Z J Psychiatry. 2020 Mar;54(3):288-297. doi: 10.1177/0004867419891246. Epub 2019 Dec 8. Aust N Z J Psychiatry. 2020. PMID: 31813230 Clinical Trial.

Cite

Share

4

Cite

Share

Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca.

Galvão-Coelho NL, de Menezes Galvão AC, de Almeida RN, Palhano-Fontes F, Campos Braga I, Lobão Soares B, Maia-de-Oliveira JP, Perkins D, Sarris J, de Araujo DB. Galvão-Coelho NL, et al. Among authors: sarris j. J Psychopharmacol. 2020 Oct;34(10):1125-1133. doi: 10.1177/0269881120936486. Epub 2020 Jul 10. J Psychopharmacol. 2020. PMID: 32648790 Clinical Trial.

Cite

Share

5

Cite

Share

Herbal medicines in the treatment of psychiatric disorders: a systematic review.

Sarris J. Sarris J. Phytother Res. 2007 Aug;21(8):703-16. doi: 10.1002/ptr.2187. Phytother Res. 2007. PMID: 17562566 Review.

Cite

Share

6

Cite

Share

St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.

Sarris J, Kavanagh DJ, Deed G, Bone KM. Sarris J, et al. Hum Psychopharmacol. 2009 Jan;24(1):41-8. doi: 10.1002/hup.994. Hum Psychopharmacol. 2009. PMID: 19090505 Clinical Trial.

Cite

Share

7

Cite

Share

Major depressive disorder and nutritional medicine: a review of monotherapies and adjuvant treatments.

Sarris J, Schoendorfer N, Kavanagh DJ. Sarris J, et al. Nutr Rev. 2009 Mar;67(3):125-31. doi: 10.1111/j.1753-4887.2009.00180.x. Nutr Rev. 2009. PMID: 19239627 Review.

Cite

Share

8

Cite

Share

Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.

Sarris J, Kavanagh DJ, Adams J, Bone K, Byrne G. Sarris J, et al. Complement Ther Med. 2009 Jun;17(3):176-8. doi: 10.1016/j.ctim.2009.01.001. Epub 2009 Feb 7. Complement Ther Med. 2009. PMID: 19398072 Clinical Trial.

Cite

Share

9

Cite

Share

Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.

Sarris J, Kavanagh DJ. Sarris J, et al. J Altern Complement Med. 2009 Aug;15(8):827-36. doi: 10.1089/acm.2009.0066. J Altern Complement Med. 2009. PMID: 19614563 Review.

Cite

Share

10

Cite

Share

Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines.

Sarris J, Kavanagh DJ, Byrne G. Sarris J, et al. J Psychiatr Res. 2010 Jan;44(1):32-41. doi: 10.1016/j.jpsychires.2009.06.003. Epub 2009 Jul 17. J Psychiatr Res. 2010. PMID: 19616220 Review.

Cite

Share